MeiraGTx Holdings PLC at Barclays Global Healthcare Conference Transcript
Thank you, everyone. My name is Gena Wang. I'm SMID cap biotech analyst at the Barclays. I first hope that everyone stays healthy, and I would like to thank all of the participants, investors, companies and, especially, our event team and the corporate access team who made this virtual health care conference possible. With that, I would like to introduce our first speaker today, Zandy Forbes, Chief Executive Officer from MeiraGTx. Zandy, I hand over to you.
Thank you, Gena. And again, thank you to Barclays for making the virtual conference possible. I'm Zandy Forbes, I'm the CEO of Meira Gene Therapy. And I'm going to give a very quick overview of the company and then Gena and I are going to go into a Q&A.
So I think you have our slides. I bring your attention to the forward-looking statements here listed in Slide 2.
And moving to Slide #3, which is an overview of really the structure and strategy of
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
